LAMEA Parenteral Nutrition Market Size

LAMEA Parenteral Nutrition Market Size & Forecast 2021-2027

LAMEA Parenteral Nutrition Market By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : September-2021 | Number of Pages : 64 | Format : PDF

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Parenteral Nutrition Market, by Nutrient Type
1.4.2 LAMEA Parenteral Nutrition Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 Impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Parenteral Nutrition Market by Nutrient Type
3.1 LAMEA Single Dose Amino Acid Solution Market by Country
3.2 LAMEA Parenteral Lipid Emulsion Market by Country
3.3 LAMEA Carbohydrates Market by Country
3.4 LAMEA Trace Elements Market by Country
3.5 LAMEA Other Nutrient Type Market by Country

Chapter 4. LAMEA Parenteral Nutrition Market by Country
4.1 Brazil Parenteral Nutrition Market
4.1.1 Brazil Parenteral Nutrition Market by Nutrient Type
4.2 Argentina Parenteral Nutrition Market
4.2.1 Argentina Parenteral Nutrition Market by Nutrient Type
4.3 UAE Parenteral Nutrition Market
4.3.1 UAE Parenteral Nutrition Market by Nutrient Type
4.4 Saudi Arabia Parenteral Nutrition Market
4.4.1 Saudi Arabia Parenteral Nutrition Market by Nutrient Type
4.5 South Africa Parenteral Nutrition Market
4.5.1 South Africa Parenteral Nutrition Market by Nutrient Type
4.6 Nigeria Parenteral Nutrition Market
4.6.1 Nigeria Parenteral Nutrition Market by Nutrient Type
4.7 Rest of LAMEA Parenteral Nutrition Market
4.7.1 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type

Chapter 5. Company Profiles
5.1 Vifor Pharma Management Ltd.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Research & Development Expenses
5.2 Baxter International, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Partnerships, Collaborations, and Agreements:
5.2.1.2 Product Launches and Product Expansions:
5.2.1.3 Approvals and Trails:
5.3 Allergan PLC (AbbVie)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expense
5.4 B. Braun Melsungen AG
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expenses
5.5 Fresenius SE & Co. KGaA
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.6 Grifols S.A.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expense
5.7 Pfizer, Inc.
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Regional Analysis
5.7.4 Research & Development Expenses
5.8 ICU Medical, Inc.
5.8.1 Company Overview
5.8.2 Recent strategies and developments:
5.8.2.1 Partnerships, Collaborations, and Agreements:
5.9 Anhui Medipharm Co., Ltd.
5.9.1 Company Overview
5.10. Aculife Healthcare Private Limited
5.10.1 Company Overview

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities